Hemoglobin stability impact on healthcare resource utilization and costs among dialysis-dependent patients with anemia of end-stage kidney disease.

ABSTRACT:

Background

The impact of hemoglobin stability on healthcare resource utilization (HCRU) and costs in dialysis-dependent patients with anemia of end-stage kidney disease (ESKD) was evaluated.

Methods

This retrospective, observational study used Optum's de-identified Market Clarity Data (Optum^® Market Clarity) (2017-2019). Dialysis-dependent patients with anemia of ESKD were stratified by mean hemoglobin level (below, within, or above the target range of 10.0-11.5 g/dL) and time within hemoglobin target range (TiR; high, ≥ 60% or low, < 60% of hemoglobin measurements within the target range) over a 9-month exposure assessment period following initiation of anemia treatment. Incidence rates of HCRU per-person year and annual mean costs were compared between groups we

SUBMITTER: Coutinho AD 

PROVIDER: S-EPMC12363002 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature